Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time

P van de Borne; Joseph Selvanayagam; J George; J. Lee; M Mattheus; H J Woerle; D Fitchett

Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time

P van de Borne, Joseph Selvanayagam, J George, J. Lee, M Mattheus, H J Woerle, D Fitchett

College of Medicine and Public Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S534-S535
Number of pages	2
Journal	Diabetologia
Volume	59
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{dec8ffbb8d7b436594fecab49541fa43,

title = "Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time",

author = "{van de Borne}, P and Joseph Selvanayagam and J George and J. Lee and M Mattheus and Woerle, {H J} and D Fitchett",

year = "2016",

language = "English",

volume = "59",

pages = "S534--S535",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time

AU - van de Borne, P

AU - Selvanayagam, Joseph

AU - George, J

AU - Lee, J.

AU - Mattheus, M

AU - Woerle, H J

AU - Fitchett, D

PY - 2016

Y1 - 2016

M3 - Article

SN - 0012-186X

VL - 59

SP - S534-S535

JO - Diabetologia

JF - Diabetologia

ER -